This contract expires in 18 days (Sep 30, 2026).
ORTHO-CLINICAL DIAGNOSTICS, INC - ORTHO VISION REAGENTS FOR BDAACH KOREA
Key Details
Description
ORTHO VISION REAGENTS FOR BDAACH KOREA
Context & Analysis
On Dec 4, 2025, Department of Defense obligated $147,759.58 to ORTHO-CLINICAL DIAGNOSTICS, INC for ortho vision reagents for bdaach korea. The award is classified under NAICS 325413 — IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING and issued as a firm fixed price contract. Competition extent: not competed under sap. The contract is scheduled through Sep 30, 2026 — approximately 1 month remaining. This award is one of several similar procurements from Department of Defense under NAICS 325413 — related awards are listed below.
Contractor Information
Similar Awards
NUCLEIC ACID ACTIVE REAGENTS AND ASSAY KITS FOR PANTHER AND FUSION INSTRUMENTS FOR TAMC 03/01/2022-09/30/2026
HOLOGIC SALES AND SERVICE, LLC
$2.0M
VARIOUS REAGENTS FOR GENEXPERT INFINITY SYSTEM MOLECULAR ANALYZER AND RENTAL/SERVICE OF ANALYZER. BASE PERIOD: 1 OCT 2021 - 30 SEP 2022
CEPHEID
$2.0M
FY25 SAF IMMUNO-ANALYZERS MICROBIOLOGY
FISHER SCIENTIFIC COMPANY L.L.C.
$1.6M
EQUIPMENT AND SUPPLIES FOR THE TOTAL LABORATORY AUTOMATION SYSTEM INCLUDING CLINICAL CHEMISTRY, IMMUNOCHEMISTRY, HEMATOLOGY, COAGULATION, AND SEROLOGY AT THE LANDSTUHL REGIONAL MEDICAL CENTER, GERMANY.
BECKMAN COULTER GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG
$1.6M
FOR MOLECULAR TRANSPLANT, RESPIRATORY, AND SEXUAL HEALTH TESTING DEPARTMENT OF PATHOLOGY AND AREA LABORATORY SERVICES
ABBOTT MOLECULAR INC.
$1.5M
Stay Updated
Get notified about new opportunities matching your interests.